Skip to main content
. 2023 Sep 1;13:14359. doi: 10.1038/s41598-023-41490-x

Figure 4.

Figure 4

The knockdown of Nrf2 increased the cytotoxic effects of oxaliplatin and lobaplatin on CRC cells. (A) The stable knockdown of Nrf2 in HCT116 and LOVO cells after lentivirus transfection. (B, C) The knockdown of Nrf2 enhanced the inhibitory effects of oxaliplatin and lobaplatin on the viability of CRC cells by the MTS assay. (DF) Compared to oxaliplatin or lobaplatin alone, the knockdown of Nrf2 combined with oxaliplatin or lobaplatin formed fewer colonies in CRC cells. (GJ) The knockdown of Nrf2 promoted oxaliplatin-induced and lobaplatin-induced apoptosis by flow cytometry. Data are shown as the mean ± SD, *p < 0.05; **p < 0.01; ***p < 0.001; ns (not significant).